Kimmtrak (tebentafusp)

pCPA File Number: 22149

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of human leukocyte antigen (HLA)-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma

Sponsor/Manufacturer:

Medison Pharma Canada Inc.

CADTH Project Number:

PC0290

pCPA Engagement Letter Issued:

2023-05-09

Negotiation Process Concluded:

2023-10-23